IMPROVE bleeding risk score: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | |||
{{CMG}}; {{AE}} {{Rim}} | {{CMG}}; {{AE}} {{Rim}} | ||
Line 48: | Line 49: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Hematology]] | |||
[[Category:Angiology]] | |||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
{{WH}} | |||
{{WS}} |
Revision as of 01:46, 5 June 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
The IMPROVE bleeding risk score estimates the risk of bleeding among acutely ill hospitalized patients.[1]
IMPROVE Bleeding Risk Score
Calculation of the IMPROVE Bleeding Risk Score
Variable | Score[1] |
Active gastric or duodenal ulcer | 4.5 |
Prior bleeding within the last 3 months | 4 |
Thrombocytopenia (<50x109/L) | 4 |
Age ≥ 85 years | 3.5 |
Liver failure (INR>1.5) | 2.5 |
Severe kidney failure (GFR< 30 mL/min/m2) | 2.5 |
Admission to ICU or CCU | 2.5 |
Central venous catheter | 2 |
Rheumatic disease | 2 |
Active malignancy | 2 |
Age: 40-84 years | 1.5 |
Male | 1 |
Moderate kidney failure (GFR: 30-59 mL/min/m2) | 1 |
Interpretation of the IMPROVE Bleeding Risk Score
The IMPROVE risk score for bleeding can be interpreted as such:[1]
- Score ≥7: Elevated risk of bleeding
- Score <7: Not elevated risk of bleeding
References
- ↑ 1.0 1.1 1.2 Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK; et al. (2011). "Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators". Chest. 139 (1): 69–79. doi:10.1378/chest.09-3081. PMID 20453069.